Dennis L Kolson
Overview
Explore the profile of Dennis L Kolson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dalmau J, Dalakas M, Kolson D, Paul F, Sanchez-Valle R, Zamvil S
Neurol Neuroimmunol Neuroinflamm
. 2023 Jan;
10(1).
PMID: 36596717
No abstract available.
12.
Grethlein D, Pirrone V, Devlin K, Dampier W, Szep Z, Winston F, et al.
Front Neurosci
. 2022 Sep;
16:912766.
PMID: 36090285
Significance: Existing screening tools for HIV-associated neurocognitive disorders (HAND) are often clinically impractical for detecting milder forms of impairment. The formal diagnosis of HAND requires an assessment of both cognition...
13.
Kolson D
Curr HIV/AIDS Rep
. 2022 Jul;
19(5):344-357.
PMID: 35867211
Purpose Of Review: Reducing the risk of HIV-associated neurocognitive disorders (HAND) is an elusive treatment goal for people living with HIV. Combination antiretroviral therapy (cART) has reduced the prevalence of...
14.
Garcia-Mesa Y, Xu H, Vance P, Gruenewald A, Garza R, Midkiff C, et al.
Antioxidants (Basel)
. 2021 Apr;
10(3).
PMID: 33803289
Dimethyl fumarate (DMF), an antioxidant/anti-inflammatory drug approved for the treatment of multiple sclerosis, induces antioxidant enzymes, in part through transcriptional upregulation. We hypothesized that DMF administration to simian immunodeficiency virus...
15.
Bui K, Wamsley C, Shofer F, Kolson D, Johnson M
IEEE Trans Neural Syst Rehabil Eng
. 2021 Feb;
29:576-586.
PMID: 33534709
There is a pressing need for strategies to slow or treat the progression of functional decline in people living with HIV. This paper explores a novel rehabilitation robotics approach to...
16.
Dalmau J, Dalakas M, Kolson D, Paul F, Zamvil S
Neurol Neuroimmunol Neuroinflamm
. 2021 Jan;
8(1).
PMID: 33411673
No abstract available.
17.
Bui K, Wamsley C, Shofer F, Kolson D, Johnson M
medRxiv
. 2020 Nov;
PMID: 33173932
There is a pressing need for strategies to slow or treat the progression of functional decline in people living with HIV. This paper explores a novel rehabilitation robotics approach to...
18.
Gruenewald A, Garcia-Mesa Y, Gill A, Garza R, Gelman B, Kolson D
J Neurovirol
. 2020 Sep;
26(6):846-862.
PMID: 32910432
Previous studies showed that persons living with HIV (PLWH) demonstrate higher brain prefrontal cortex neuroinflammation and immunoproteasome expression compared to HIV-negative individuals; these associate positively with HIV levels. Lower expression...
19.
Garcia-Mesa Y, Garza R, Diaz Ortiz M, Gruenewald A, Bastien B, Lobrovich R, et al.
J Virol
. 2020 Jul;
94(19).
PMID: 32669339
Brain injury occurs within days in simian immunodeficiency virus (SIV) or human immunodeficiency virus (HIV) infection, and some recovery may occur within weeks. Inflammation and oxidative stress associate with such...
20.
Garza R, Gill A, Bastien B, Garcia-Mesa Y, Gruenewald A, Gelman B, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Apr;
7(3).
PMID: 32277015
Objective: To determine whether regulatory variations in the heme oxygenase-1 (HO-1) promoter (GT) dinucleotide repeat length could identify unique population genetic risks for neurocognitive impairment (NCI) in persons living with...